The utility of a deep learning-based approach in Her-2/neu assessment in breast cancer
IntroductionHER-2/neu is a protein present on the surface of specific cancer cells and has been linked to the development and progression of certain cancer types. It is present in 15 to 20% of breast cancers and is clinically significant due to the availability of multiple anti-Her2 treatment option...
محفوظ في:
| المؤلف الرئيسي: | Saidul, Kabir (author) |
|---|---|
| مؤلفون آخرون: | Vranic, Semir (author), Mahmood Al Saady, Rafif (author), Salman Khan, Muhammad (author), Sarmun, Rusab (author), Alqahtani, Abdulrahman (author), Abbas, Tariq O. (author), Chowdhury, Muhammad E.H. (author) |
| التنسيق: | article |
| منشور في: |
2023
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://dx.doi.org/10.1016/j.eswa.2023.122051 https://www.sciencedirect.com/science/article/pii/S0957417423025538 http://hdl.handle.net/10576/53087 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
The utility of a deep learning-based approach in Her-2/neu assessment in breast cancer
حسب: Saidul Kabir (15302407)
منشور في: (2024) -
Deep learning and vision transformers-based framework for breast cancer and subtype identification
حسب: Ishrat Jahan (5782163)
منشور في: (2025) -
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer
حسب: Kheraldine, Hadeel
منشور في: (2025) -
Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications
حسب: Sara S Bashraheel (17807612)
منشور في: (2023) -
Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways
حسب: Hadeel, Kheraldine
منشور في: (2021)